About the Authors

Desmond B. S. Pink

Affiliation Innovascreen, Inc., Halifax, Nova Scotia, Canada

Wendy Schulte

Affiliation Innovascreen, Inc., Halifax, Nova Scotia, Canada

Missag H. Parseghian

Affiliation Stonsa Biopharm Inc., Carlsbad, California, United States of America

Andries Zijlstra

Affiliations Innovascreen, Inc., Halifax, Nova Scotia, Canada, Department of Pathology, Vanderbilt University, Nashville, Tennesee, United States of America

John D. Lewis

jdlewis@ualberta.ca

Affiliations Innovascreen, Inc., Halifax, Nova Scotia, Canada, Department of Oncology, University of Alberta, Edmonton, Alberta, Canada

Competing Interests

The authors have read the journal's policy and have the following conflicts: Dr. Lewis and Dr. Zijlstra are employees of Innovascreen Inc. and hold stock in Innovascreen Inc. Dr. Pink and Dr. Schulte are employees of Innovascreen Inc. Dr. Parseghian is an employee of Stonsa Biopharm Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: DP AZ JL. Performed the experiments: DP WS. Analyzed the data: DP AZ JL. Contributed reagents/materials/analysis tools: MP. Wrote the paper: DP MP AZ JL.